Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1979 Oct;8(4):373–375. doi: 10.1111/j.1365-2125.1979.tb04724.x

Acebutolol saliva excretion.

J F Giudicelli, J L Freslon, C Richer
PMCID: PMC1429831  PMID: 41552

Full text

PDF
373

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basil B., Jordan R., Loveless A. H., Maxwell D. R. Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A. Br J Pharmacol. 1973 Jun;48(2):198–211. doi: 10.1111/j.1476-5381.1973.tb06906.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DAWES C., JENKINS G. N. THE EFFECTS OF DIFFERENT STIMULI ON THE COMPOSITION OF SALIVA IN MAN. J Physiol. 1964 Jan;170:86–100. doi: 10.1113/jphysiol.1964.sp007315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dawes C. P., Kendall M. J., John V. A. Comparison of plasma and saliva levels of metoprolol and oxprenolol. Br J Clin Pharmacol. 1978 Mar;5(3):217–221. doi: 10.1111/j.1365-2125.1978.tb01627.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Decourt S., Roux A., Baglin A., Domart M., Aubert P., Flouvat B., Fritel D. Etude de la fixation des béta-bloquants aux protéines plasmatiques. Incidences thérapeutiques. Acquis Med Recent. 1977:181–194. [PubMed] [Google Scholar]
  5. Kaye C. M., Kumana C. R., Leighton M., Hamer J., Turner P. Observations on the pharmacokinetics of acebutolol. Clin Pharmacol Ther. 1976 Apr;19(4):416–420. doi: 10.1002/cpt1976194416. [DOI] [PubMed] [Google Scholar]
  6. Lowenthal D. T., Pitone J. M., Affrime M. B., Shirk J., Busby P., Kim K. E., Nancarrow J., Swartz C. D., Onesti G. Timolol kinetics in chronic renal insufficiency. Clin Pharmacol Ther. 1978 May;23(5):606–615. doi: 10.1002/cpt1978235606. [DOI] [PubMed] [Google Scholar]
  7. Meffin P. F., Harapat S. R., Harrison D. C. Quantitation in plasma and urine of acebutolol and a major metabolite with preliminary observations on their disposition kinetics in man. Res Commun Chem Pathol Pharmacol. 1976 Sep;15(1):31–51. [PubMed] [Google Scholar]
  8. Meffin P. J., Harapat S. R., Yee Y. G., Harrison D. C. High-pressure liquid chromatographic analysis of drugs in biological fluids. V. Analysis of acebutolol and its major metabolite. J Chromatogr. 1977 Aug 1;138(1):183–191. doi: 10.1016/s0021-9673(00)98009-9. [DOI] [PubMed] [Google Scholar]
  9. Mucklow J. C., Bending M. R., Kahn G. C., Dollery C. T. Drug concentration in saliva. Clin Pharmacol Ther. 1978 Nov;24(5):563–570. doi: 10.1002/cpt1978245563. [DOI] [PubMed] [Google Scholar]
  10. Roux A., Flouvat B. Méthode sensible de dosage de l'acébutolol et de son métabolite N-acétylé dans les milieux biologiques par chromatographie liquide haute performance avec détection de fluorescence. J Chromatogr. 1978 Dec 1;166(1):327–332. doi: 10.1016/s0021-9673(00)92284-2. [DOI] [PubMed] [Google Scholar]
  11. Taylor E. A., Kaspi T. L., Turner P. The pH dependent absorption of propranolol and indomethacin by Parafilm, a stimulant of salivary secretion. J Pharm Pharmacol. 1978 Dec;30(12):813–814. doi: 10.1111/j.2042-7158.1978.tb13405.x. [DOI] [PubMed] [Google Scholar]
  12. Winkle R. A., Meffin P. J., Ricks W. B., Harrison D. C. Acebutolol metabolite plasma concentration during chronic oral therapy. Br J Clin Pharmacol. 1977 Oct;4(5):519–522. doi: 10.1111/j.1365-2125.1977.tb00779.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES